Detalhe da pesquisa
1.
Transplantation outcomes in patients with primary hyperoxaluria: a systematic review.
Pediatr Nephrol
; 36(8): 2217-2226, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33830344
2.
Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1.
Kidney Int
; 103(5): 990-993, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36871948
3.
Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy.
Kidney Int
; 104(1): 203-204, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37349052
4.
Corrigendum to "Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy." Kidney International, 2023;104:203-204.
Kidney Int
; 104(5): 1038, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37863627
5.
Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1.
Nephrol Dial Transplant
; 38(7): 1773-1775, 2023 Jun 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36898675
6.
The appearance of oxalate crystals in a kidney biopsy is no proof of post-transplant oxalate nephropathy in primary hyperoxaluria type 1.
Kidney Int
; 102(2): 446, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35870818
7.
Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium.
Kidney Int Rep
; 8(10): 2029-2042, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37849991
8.
Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry.
Kidney Int Rep
; 7(2): 210-220, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35155860